Immunology of Infection

Dieter Kabelitz is full professor at the University of Kiel, Germany, and Director of the Institute of Immunology. Dieter Kabelitz studied medicine in Freiburg and Munich, Germany. He was a post-doc in Uppsala/Sweden and at Rockefeller University, New York. In 1988, he was appointed Associate Professor for Cellular Immunology at the University of Heidelberg. From 1992 to 1999 he was Head of the Department of Immunology at the Paul-Ehrlich Institute in Langen, Germany. Since 1999 he is a full professor at the University of Kiel and Director of the Institute of Immunology. His scientific expertise is in the field of the functional characterization of human T cells with a special focus on  T cells. Current projects aim to explore the potential of human  T cells for the immunotherapy of cancer. He has published more than 360 papers listed in PubMed/Medline. Dieter Kabelitz was chairman of the Collaborative Research Center (SFB) 415 „Specificity and Pathophysiology of Signal Transduction Pathways“ funded at Kiel University by the German Research Foundation (DFG). He is a founding member and member of the Steering Committee of the DFG-funded Cluster of Excellence „Inflammation-at-Interfaces“. He was President of the German Society for Immunology (DGfI) in 2011 and 2012, and he is a Council member of the International Union of Immunological Societies (IUIS) and chair of the Education Committee (EDU) of IUIS.

Praise for the first edition:"The book is clearly presented, packed with protocols, and well illustrated" --Microbiology Today"...it represents a valuable addition to the microbiologists' reference source." --Immunology Today

• I. General MethodsRadbruch A - Phenotyping and isolation of functionally distinct leukocyte populations; Schütze S - Magnetic isolation of subcellular compartments; Berzofsky J - Prediction of MHC ligands and T-cell epitopes; McMichael A - Quantitative analysis of T-cell responses; Schurr E - Genetics of susceptibility and resistance to infection; Wiker H - Proteomic approaches to study immunity in infection; Sioud M - siRNA as a tool to study immune responses in infection; Schröder JM - Isolation and characterization of antimicrobial peptides; Karin M - Toll - and NOD-like receptors in anti-infective immunity; von Andrian UH - Visualization of immune responses in vivoII. Murine ModelsA. In vitro analysisCzuprynski CJ - Isolation of lymphocytes from infected animals; Busch DH - Killer cell assays; Kiyono H - Quantification of murine T-cell cytokine responses; Gordon S - Isolation and functional charactzerization of macrophagesB. In vivo analysisEhlers S - Measuring immune responses in vivo; Belkaid Y - Control of infection by regulatory T-cells; Stockinger B - Th17 cells in inflammationC. Specific ModelsOrme IM - Murine models of tuberculosis; Muller I - The leishmaniasis model; Autenrieth IB - Murine models of infection with extracellular bacteria; Flynn JL - Local immune responses in the lung; Romani L - Murine models of fungal infections; Powrie F - Immunity in the gut; Reddehase MJ - Murine cytomegalovirus infection; Lingnau K/von Gabain A - Boosting of immune responses by adjuvantsIII. Human SystemBanchereau J - Subpopulations of human dendritic cells; Yssel H - Measuring human cytokine responses; Seitzer U - Measuring immune responses in situ; Garcia JV - Humanized mice for the analysis of human immune responsesIV. AppendixBenoist C - The NIH knock-out mouse project; Beutler B - Forward genetic analysis to understand innate immunity